A 40-year-old woman recently participated in a research study that incidentally identified a pathogenic variant in the transthyretin (TTR) (OMIM 176300) gene. She was reported to have a single heterozygous nucleotide variant leading to substitution of serine for tyrosine at amino acid position 97 (Ser97Tyr, SNP rs267607161). The patient is of European descent, and her medical history was notable for carpal tunnel syndrome. She was asymptomatic from a cardiopulmonary standpoint. She reported no family history of amyloidosis, but her paternal grandfather died of heart disease at age 52 years. Her physical examination results showed a blood pressure of 112/76 mm Hg and heart rate of 79/min. Her cardiovascular examination results were unremarkable, with a jugular venous pressure of 5 cm H2O, no lower extremity edema, and normal heart sounds.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Sinha A, McNally EM, Khan SS. Transthyretin Genetic Testing. JAMA Cardiol. Published online May 12, 2021. doi:10.1001/jamacardio.2021.0835
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: